ALKTERNATE: A pilot study alternating lorlatinib with crizotinib in patients with ALK+ NSCLC and ALK-inhibitor resistance Meeting Abstract


Authors: Itchins, M.; Liang, S.; Brown, C.; Barnes, T.; Marx, G.; Chin, V.; Kao, S.; Yip, P. Y.; Mersiades, A. J.; Nagrial, A.; Bray, V.; Peters, G.; Parakh, S.; John, T.; Li, M.; Li, B. T.; McKay, M.; Molloy, M.; O'Byrne, K.; Lee, C.; Gill, A.; Solomon, B. J.; Pavlakis, N.
Abstract Title: ALKTERNATE: A pilot study alternating lorlatinib with crizotinib in patients with ALK+ NSCLC and ALK-inhibitor resistance
Meeting Title: 2023 World Conference on Lung Cancer (IASLC-WCLC)
Journal Title: Journal of Thoracic Oncology
Volume: 18
Issue: 11 Suppl.
Meeting Dates: 2023 Sep 9-11
Meeting Location: Singapore
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2023-11-01
Start Page: S351
End Page: S352
Language: English
DOI: 10.1016/j.jtho.2023.09.616
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: P2.10-01 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bob Tingkan Li
    278 Li